Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast agent presented as a solution for injection for intra‑arterial and intravenous use. It enhances radiographic visibility of blood vessels and organs during imaging procedures. The product conforms to EU pharmacopeial standards and is manufactured under strict quality controls. It is indicated for use in diagnostic angiography, computed tomography and urography procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres, clinics and research institutions worldwide.

Iomeron, an iodinated contrast agent, is used to improve X‑ray based imaging of vascular and organ systems. - Angiography: provides enhanced visualization of blood vessels to aid diagnostic and interventional procedures. - Computed tomography (CT) scans: increases contrast between tissues, facilitating detection of lesions and anatomical detail. - Intravenous urography: improves delineation of urinary tract structures for accurate assessment.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site. - Metallic taste or mild nausea. - Headache or mild dizziness. - Transient itching or urticaria. - Mild vomiting.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Contrast‑induced nephropathy leading to acute kidney injury. - Thyroid dysfunction, including hyperthyroidism. - Cardiac arrhythmias or hypotension in susceptible patients.

Prior to using Iomeron, clinicians should consider several safety measures. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Screen for iodine allergy: avoid in patients with known hypersensitivity to iodinated contrast. - Ensure adequate hydration: promote fluid intake to reduce risk of nephrotoxicity. - Pregnancy: use only when the diagnostic benefit outweighs potential fetal risk. - Review concurrent nephrotoxic drugs: consider alternative imaging or dose adjustments. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iomeron can interact with certain medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Metformin: increased risk of lactic acidosis if renal function is impaired. - High‑dose iodinated contrast with thyroid hormone therapy: may precipitate thyrotoxicosis. - Nephrotoxic antibiotics (e.g., aminoglycosides): heightened risk of renal injury.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid balance and renal clearance of contrast. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Beta‑blockers: may mask contrast‑induced hypertension, requiring blood pressure monitoring.